“…Finally, biomarker development is one of the biggest challenges for identifying underpinning causes of developmental disorders, which is crucial for effective therapeutic intervention ( Symons & Roberts, 2013 ; Anderson, 2015 ; Zafarullah & Tassone, 2019 ). For this, a variety of potential biomarkers for intellectual disability disorders have been proposed including monitoring of heart activity ( Tonnsen et al, 2013 ), blood cell signatures ( Sengupta et al, 2019 ), metabolic ( Berry-Kravis et al, 2015 ), inflammatory ( Manti et al, 2018 ), and signalling molecules ( Weng et al, 2008 ). Here, we show that the photoABP approach is a robust assay to monitor dysregulated RNF12 E3 activity in patients caused by TOKAS gene variants.…”